Phase II study of erlotinib in patients with advanced biliary cancer.
Philip PA, Mahoney MR, Allmer C, Thomas J, Pitot HC, Kim G, Donehower RC, Fitch T, Picus J, Erlichman C.
Philip PA, et al. Among authors: picus j.
J Clin Oncol. 2006 Jul 1;24(19):3069-74. doi: 10.1200/JCO.2005.05.3579.
J Clin Oncol. 2006.
PMID: 16809731
Clinical Trial.